2007
DOI: 10.1016/j.clon.2006.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms and Management of Non-islet Cell Tumour Hypoglycaemia in Gastrointestinal Stromal Tumour: Case Report and a Review of Published Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
15
0
2

Year Published

2008
2008
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 28 publications
0
15
0
2
Order By: Relevance
“…When these active complexes or unbound IGF-II bind to insulin and IGF receptors in the liver and peripheral tissues there is decreased release of glucose into circulation and increased peripheral glucose metabolism resulting in hypoglycemia. Although plasma IGF-II levels were within normal range, the ratio of IGF-II to IGF-I was elevated at 9.6:1, consistent with NICTH [20]. Given the humorally mediated symptoms related to these metastases, an aggressive approach for cytoreduction is warranted.…”
Section: Discussionmentioning
confidence: 93%
“…When these active complexes or unbound IGF-II bind to insulin and IGF receptors in the liver and peripheral tissues there is decreased release of glucose into circulation and increased peripheral glucose metabolism resulting in hypoglycemia. Although plasma IGF-II levels were within normal range, the ratio of IGF-II to IGF-I was elevated at 9.6:1, consistent with NICTH [20]. Given the humorally mediated symptoms related to these metastases, an aggressive approach for cytoreduction is warranted.…”
Section: Discussionmentioning
confidence: 93%
“…Under normal conditions, the liver produces IGF-II, in a growth hormone-independent manner, and IGF-II forms a biologically inactive ternary complex with IGF binding proteins (IGFBP), the most common of which are IGFBP3 and acid labile subunit (ALS) [12, 13]. Tumor-produced IGF-II has an equal affinity for IGFBPs compared to IGFI and II.…”
Section: Discussionmentioning
confidence: 99%
“…En los pacientes con hipoglicemia paraneoplásica se ha encontrado niveles plasmáticos de insulina baja, niveles elevados de 'big IGF-II' ( factor incompleto de crecimiento similar a la insulina tipo II), producto de un error en el procesamiento del IGF II, y aumento de su biodisponibilidad por una distribución alterada entre sus proteínas transportadoras (24)(25)(26) . El diagnóstico de hipoglicemia paraneoplásica se vio facilitado por los antecedentes negativos de diabetes mellitus, el no uso de fármacos o drogas (hipoglicemiantes orales, insulina, ácido acetil salicílico, alcohol, entre otros), ausencia de infecciones u otras enfermedades metabólicas, nutricionales, y por la presencia de derrame pericárdico masivo.…”
Section: Discussionunclassified